Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BioCryst Pharmaceuticals
In this study, 24 healthy subjects will be randomized to receive a single dose of two formulations of BCX7353 and one of the formulations administered with a high-fat meal. A 14-day washout period will separate each dose.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
written informed consent
acceptable birth control measures for male subjects and women of childbearing potential
complies with all required study procedures and restrictions
You may not be if
clinically significant medical history, current medical or psychiatric condition
clinically significant ECG finding, vital sign measurement or laboratory/urinalysis abnormality at screening or baseline
current use, or use of any prescribed or over the counter medication, vitamins or herbal products within 14 days of Day 1
participation in any other investigational drug study within 90 days of screening
recent or current history of alcohol or drug abuse
regular recent use of tobacco or nicotine products
positive serology for HBV, HCV, or HIV
pregnant or nursing
donation or loss of greater than 400 mL of blood within the previous 3 months